Home / CHF / BRIEF-Basilea Pharmaceutica: CHF 10 Million Milestone Payment For Cresemba Sales

BRIEF-Basilea Pharmaceutica: CHF 10 Million Milestone Payment For Cresemba Sales

Dec 10 (Reuters) – Basilea Pharmaceutica AG: * CONTINUED STRONG CRESEMBA® (ISAVUCONAZOLE) U.S. SALES PERFORMANCE BY ASTELLAS PHARMA INC. TRIGGERS CHF 10 MILLION MILESTONE PAYMENT TO BASILEA * BASILEA …
Read Full Story at source (may require registration)